✦ LIBER ✦

High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study

✍ Scribed by Carol Evans; A. Winkelstein; C. S. Rosenfeld; Z. R. Zeigler; R. K. Shadduck

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 654 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900615)65:12<2624::aid-cncr2820651204>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of “poor risk” acute nonlympho

Treatment of “poor risk” acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside

✍ Dr. Edward P. Balaban; John V. Cox; Nancy R. Schneider; Cheryl A. Harth; Barbara 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

High-dose cytosine arabinoside and L-asp

High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: The Children's Cancer Group Experience

✍ Harris, Richard E.; Sather, Harland N.; Feig, Stephen A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Problem. Therapy of children with relapsed acute lymphoblastic leukemia (ALL) not achieving a second remission (CR2) after an initial reinduction attempt is problematic. Methods. 52 children with ALL in first relapse received high-dose cytosine arabinoside and L-asparaginase (HDAraC/L-Asp) after fa

The role of timing of high-dose cytosine

The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia

✍ William G. Woods; Frederick B. Ruymann; Beatrice C. Lampkin; Jonathan D. Buckley 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the southeastern cancer study group

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

A pilot study of intermediate-dose metho

A pilot study of intermediate-dose methotrexate and cytosine arabinoside, “Spread-out” or “Up-front,” in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia a pediatric oncology group study

✍ Robert A. Krance; Edward M. Newman; Donald Pinkel; Yaddanapudi Ravindranath; Mic 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 723 KB

One hundred six children with newly diagnosed non-T-, non-B-cell acute lymphoblastic leukemia (ALL) were treated in a Pediatric Oncology Group (POG) pilot study in which six courses of intermediate-dose methotrexate (MTX) and cytosine arabinoside (Ara-C) (1 g/m2 each) were added to a "backbone" of s

Phase II evaluation of an intensified in

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)

✍ Stephen H. Petersdorf; Cathryn Rankin; David R. Head; Howard R. Terebelo; Cheryl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views